☆ 4.4 Article

Emetine, a small molecule natural product, displays potent anti-gastric cancer activity via regulation of multiple signaling pathways

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Gastric Cancer, Version 2.2022

Jaffer A. Ajani et al.

Summary: Gastric cancer is the third leading cause of cancer-related deaths worldwide, with over 95% being adenocarcinomas. It is often diagnosed at an advanced stage, leading to a poor prognosis. However, systemic therapy can alleviate symptoms, improve survival, and enhance quality of life. The implementation of biomarker testing has significantly impacted clinical practice and patient care. Targeted therapies have shown encouraging results in clinical trials. Palliative management is recommended for patients with unresectable or metastatic cancer.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)

添加到收藏夹

Review Oncology

Hippo in Gastric Cancer: From Signalling to Therapy

Lornella Seeneevassen et al.

Summary: The Hippo signalling pathway is important and complex in physiology, and its dysregulation can lead to cancer. In gastric carcinogenesis, the Hippo pathway and its effectors, YAP and TAZ, play a vital role. This review discusses the dysregulation of the Hippo pathway in gastric cancer and the strategies used to target it.

CANCERS (2022)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Cell Biology

Long noncoding RNA (lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation

Yuhao Luo et al.

Summary: Recent studies have shown that lncRNA EIF3J-DT is highly expressed in drug-resistant gastric cancer cells, contributing to chemoresistance by activating autophagy through targeting ATG14. This regulatory mechanism by EIF3J-DT may serve as a potential new target for enhancing chemosensitivity and improving prognosis in gastric cancer patients.

AUTOPHAGY (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

The PI3K/Akt/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions

Ayda Baghery Saghchy Khorasani et al.

Summary: Genetic and epigenetic alterations have long been the focus of cancer pathogenesis research, with dysregulated genes and protein products potentially affecting cancer cell growth through signaling cascades regulating cell survival and metabolism. The activation of the phosphatidylinositol-3-kinase (PI3K) axis in about one-third of human cancers, including gastric cancer, plays a significant role in the development of malignancies. This indicates the potential importance of targeting this axis in therapeutic strategies for such cancers.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

添加到收藏夹

Article Oncology

Targeting cPLA2α inhibits gastric cancer and augments chemotherapy efficacy via suppressing Ras/MEK/ERK and Akt/β-catenin pathways

Yingying Liao et al.

Summary: The study showed that upregulation of cPLA2alpha is common in gastric cancer patients with metastasis, and its overexpression promotes cell growth and migration while its depletion inhibits these processes. Decreasing cPLA2alpha can enhance chemotherapy efficacy by mainly regulating Ras/MEK/ERK and possibly Akt/beta-catenin pathways in gastric cancer cells.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Emetine exerts anticancer effects in U2OS human osteosarcoma cells via activation of p38 and inhibition of ERK, JNK, and β-catenin signaling pathways

Juhyeon Son et al.

Summary: Emetine exhibits significant anticancer and antimetastatic effects on human osteosarcoma cells through various cellular mechanisms, including inhibition of cell viability and proliferation, induction of apoptosis, and suppression of migration and invasion. It also affects the activities of matrix metalloproteinases and signaling pathways related to apoptosis and expression of matrix metalloproteinases. Emetine shows potential as a promising drug candidate for chemotherapy of osteosarcoma.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2021)

添加到收藏夹

Article Oncology

Oxidative stress as candidate therapeutic target to overcome microenvironmental protection of CLL

Deyan Yordanov Yosifov et al.

LEUKEMIA (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Molecular Mechanism of Resistance to Chemotherapy in Gastric Cancers, the Role of Autophagy

Liudmila Spirina et al.

CURRENT DRUG TARGETS (2020)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Irinotecan Induces Autophagy-Dependent Apoptosis and Positively Regulates ROS-Related JNK- and P38-MAPK Pathways in Gastric Cancer Cells

Qingyun Zhu et al.

ONCOTARGETS AND THERAPY (2020)

添加到收藏夹

Review Oncology

Targeted Therapies in Advanced Gastric Cancer

Timil H. Patel et al.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Resistance to FGFR1-targeted therapy leads to autophagy via TAK1/AMPK activation in gastric cancer

Rui Peng et al.

GASTRIC CANCER (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Targeting Wnt Signaling for the Treatment of Gastric Cancer

Sarah Koushyar et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Article Oncology

Leukaemia Inhibitory Factor (LIF) Inhibits Cancer Stem Cells Tumorigenic Properties through Hippo Kinases Activation in Gastric Cancer

Lornella Seeneevassen et al.

CANCERS (2020)

添加到收藏夹

Review Oncology

Gastric cancer: a comprehensive review of current and future treatment strategies

Rachel E. Sexton et al.

CANCER AND METASTASIS REVIEWS (2020)

添加到收藏夹

Review Oncology

Molecular target: pan-AKT in gastric cancer

Byung Woog Kang et al.

ESMO OPEN (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Low dose of emetine as potential anti-SARS-CoV-2 virus therapy: preclinical in vitro inhibition and in vivo pharmacokinetic evidences

Aoli Wang et al.

MOLECULAR BIOMEDICINE (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Progress and current status of molecule-targeted therapy and drug resistance in gastric cancer

Z. Chen et al.

DRUGS OF TODAY (2020)

添加到收藏夹

Article Oncology

A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer

Y-J Bang et al.

EUROPEAN JOURNAL OF CANCER (2019)

添加到收藏夹

Article Oncology

Emetine exhibits anticancer activity in breast cancer cells as an antagonist of Wnt/β-catenin signaling

Qi Sun et al.

ONCOLOGY REPORTS (2019)

添加到收藏夹

Article Oncology

Silymarin induces inhibition of growth and apoptosis through modulation of the MAPK signaling pathway in AGS human gastric cancer cells

Sung-Hyun Kim et al.

ONCOLOGY REPORTS (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Emetine Synergizes with Cisplatin to Enhance Anti-Cancer Efficacy against Lung Cancer Cells

Ti-Hui Wu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

添加到收藏夹

Article Medicine, General & Internal

A clinical analysis of systemic chemotherapy combined with radiotherapy for advanced gastric cancer

Hong-Min Dong et al.

MEDICINE (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

The HER4-YAP1 axis promotes trastuzumab resistance in HER2-positive gastric cancer by inducing epithelial and mesenchymal transition

Jiaolong Shi et al.

ONCOGENE (2018)

添加到收藏夹

Article Cell Biology

Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry

Shu Yang et al.

CELL DISCOVERY (2018)

添加到收藏夹

Letter Oncology

Emetine induces estrogen receptor alpha degradation and prevents 17β-estradiol-induced breast cancer cell proliferation

Claudia Busonero et al.

CELLULAR ONCOLOGY (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Emetine inhibits migration and invasion of human non-small-cell lung cancer cells via regulation of ERK and p38 signaling pathways

Ji Hyun Kim et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2015)

添加到收藏夹

Article Oncology

A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer

Shi Jiao et al.

CANCER CELL (2014)

添加到收藏夹

Article Gastroenterology & Hepatology

Treatment of early gastric cancer in the Western World

Elfriede Bollschweiler et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

添加到收藏夹

Article Oncology

Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis

Wei Kang et al.

CLINICAL CANCER RESEARCH (2011)

添加到收藏夹

Article Plant Sciences

Terpenoid tetrahydroisoquinoline alkaloids emetine, klugine, and isocephaeline inhibit the activation of hypoxia-inducible factor-1 in breast tumor cells

YD Zhou et al.

JOURNAL OF NATURAL PRODUCTS (2005)

添加到收藏夹

Review Oncology

5-Fluorouracil: Mechanisms of action and clinical strategies

DB Longley et al.

NATURE REVIEWS CANCER (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.